Nexalin Technology, Inc.: Nexalin Technology Announces Reverse Stock Split

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

Nexalin Technology (NXL) reported positive eight-week clinical trial results for its non-invasive DIFS neurostimulation in adults with generalized anxiety disorder and comorbid insomnia. Conducted at the University of São Paulo’s Institute of Psychiatry, the study used a 15 mA, 77.5 Hz protocol across 20 40-minute sessions. Nexalin said the end-of-treatment anxiety response rate was 77.8% (HAM-A drop by Session 5 and maintained at follow-up), with no serious adverse events.

Yarrow Bioscience Inc (YARW) shares fell 7% after pricing a $150 million public offering of 5.8 million shares at $26 each. The stock is currently trading at $26.55, down 6.65% from the previous close of $28.44 on the Nasdaq.

Pilgrim’s Pride Corp. (PPC) and its subsidiary are offering up to 500 million euros in senior notes. Proceeds will fund general corporate purposes, including the acquisition of Walkers Deli & Sausage Co. The notes are for qualified institutional buyers and certain non-U.S. persons, and will not be registered in the U.S.

USA Rare Earth (USAR) began construction on an $1.2B rare earth metal and magnet manufacturing facility in South Carolina, aiming for 2028 commissioning. The 800,000-sq-ft site will create 490 jobs and produce 6,400 metric tons of NdFeB magnets annually. The company also donated $250,000 to local workforce development. USAR seeks to reduce U.S. reliance on foreign rare earth supplies, complementing its Oklahoma operations.

BlackRock's private credit fund saw fewer redemption requests in Q3, with 11.5% of shares sought, down from 13.3% in Q2. The fund will repurchase 5% of shares, or $600 million. This suggests easing redemption pressures in the private credit industry, according to a regulatory filing.